Viewing Study NCT02909166


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-01-27 @ 1:16 PM
Study NCT ID: NCT02909166
Status: UNKNOWN
Last Update Posted: 2016-09-21
First Post: 2016-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.
Sponsor: Mika Lehto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module